Delphine Knight Brown News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Since the COVID-19 immunisation started almost a year ago in January 2021, 60.2 per cent of the world population has received at least one dose of a COVID-19 vaccine and only 9.4 per cent of people in low-income countries have received at least one dose (source: our world in data). While there are many challenges to do so, the repeated argument being ‘pharma companies should forego Intellectual Property (IP) to expedite universal immunisation’. Should pharma companies waive IP during the pandemic? Will this ensure universal immunisation and equal distribution of therapies? Let’s find out.
....

United States , United Kingdom , Australian Capital Territory , Bruce Baer Arnold , Jaci Mcdole , Astra Zeneca , Samsung Biologics , Ayesha Siddiqui , Delphine Knight Brown , Canberra Law School , World Health Organisation , Freeborn Peters , Information Technology , Property Practice Group , Technology Access Pool , Serum Institute , World Trade Organisation , Oxford University , Innovation Foundation , Trade Related Aspects , Intellectual Property Rights , Intellectual Property Practice Group , Associate Professor , Senior Policy Analyst , Access Pool ,